Premal S. Shah
Directeur Général chez MyOme, Inc.
Profil
Premal S.
Shah is currently the Chief Executive Officer at MyOme, Inc. Prior to this, he worked as the Vice President of Business Development at Applied Proteomics, Inc. from 2013 to 2015.
He holds a doctorate degree from the California Institute of Technology.
Postes actifs de Premal S. Shah
| Sociétés | Poste | Début |
|---|---|---|
MyOme, Inc.
 MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | Directeur Général | - |
Anciens postes connus de Premal S. Shah
| Sociétés | Poste | Fin |
|---|---|---|
Applied Proteomics, Inc.
 Applied Proteomics, Inc. Medical/Nursing ServicesHealth Services Applied Proteomics, Inc. develops protein biomarkers for the healthcare and drug development sectors. It specializes in blood-based multiplex protein tests to help physicians, direct patients towards current standard-of-care patient management. The company was founded by David B. Agus and W. Daniel Hillis in May 2007 and is headquartered in San Diego, CA. | Directeur Général | - |
Formation de Premal S. Shah
| California Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Applied Proteomics, Inc.
Applied Proteomics, Inc. Medical/Nursing ServicesHealth Services Applied Proteomics, Inc. develops protein biomarkers for the healthcare and drug development sectors. It specializes in blood-based multiplex protein tests to help physicians, direct patients towards current standard-of-care patient management. The company was founded by David B. Agus and W. Daniel Hillis in May 2007 and is headquartered in San Diego, CA. | Health Services |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | Health Technology |
